Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion type Assertion NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_head.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion description "[Our study suggests that the abnormal upregulation of FSCN1 in HCC is associated with downregulation of miR-145 and miR-133a, and miR-145 and miR-133a inhibit malignant progression of HCC in vitro, possibly via directly targeting FSCN1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_provenance.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion evidence source_evidence_literature NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_provenance.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion SIO_000772 26173501 NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_provenance.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion wasDerivedFrom befree-2016 NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_provenance.
- NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_assertion wasGeneratedBy ECO_0000203 NP1290079.RAxLVcn2RQYNC3resnX5J0P0Yme93j938xv2tGykWdoS4130_provenance.